http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#head http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#assertion http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#provenance http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#publicationInfo http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#assertion http://bio2rdf.org/drugbank:DB05484 http://bio2rdf.org/bio2rdf_vocabulary:identifier DB05484 http://bio2rdf.org/drugbank:DB05484 http://bio2rdf.org/bio2rdf_vocabulary:namespace drugbank http://bio2rdf.org/drugbank:DB05484 http://bio2rdf.org/bio2rdf_vocabulary:uri http://bio2rdf.org/drugbank:DB05484 http://bio2rdf.org/drugbank:DB05484 http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org http://identifiers.org/drugbank/DB05484 http://bio2rdf.org/drugbank:DB05484 http://bio2rdf.org/drugbank_vocabulary:drugbank-id DB05484 http://bio2rdf.org/drugbank:DB05484 http://bio2rdf.org/drugbank_vocabulary:x-cas http://bio2rdf.org/cas: http://bio2rdf.org/drugbank:DB05484 http://purl.org/dc/terms/description MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin-8) and may have potential application in oncology and inflammation. Trials will initially focus on studies to treat glioblastoma, a cancer of the central nervous system. Other possible indications include chronic obstructive pulmonary disease (COPD) and pustular dermatoses. In pre-clinical studies, HuMax-Inflam has been shown to inhibit tumor growth in tumor models using primary human tumors in immunodeficient mice. HuMax-Inflam was also effective in reducing disease activity in palmoplantar pustulosis patients in a clinical study. http://bio2rdf.org/drugbank:DB05484 http://purl.org/dc/terms/identifier drugbank:DB05484 http://bio2rdf.org/drugbank:DB05484 http://purl.org/dc/terms/title MDX-018 http://bio2rdf.org/drugbank:DB05484 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug http://bio2rdf.org/drugbank:DB05484 http://www.w3.org/2000/01/rdf-schema#label MDX-018 [drugbank:DB05484] http://bio2rdf.org/drugbank:DB05484 http://www.w3.org/2000/01/rdf-schema#seeAlso http://www.drugbank.ca/drugs/DB05484 http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#provenance http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://www.w3.org/ns/dcat#distribution http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://purl.org/dc/terms/created 2015-01-09T17:00:50-05:00 http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://www.w3.org/ns/prov#wasDerivedFrom http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://purl.org/pav/retrievedOn 2014-11-12T07:57:03-05:00 http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://www.w3.org/ns/prov#wasDerivedFrom http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip http://www.w3.org/ns/prov#wasAttributedTo http://drugbank.ca http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#publicationInfo http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#signature.MCwCFEFKQsXSuHrd http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#signature.MCwCFEFKQsXSuHrd http://purl.org/nanopub/x/hasSignature MCwCFEFKQsXSuHrdoqd3rdM3BskoHf8JAhRGZ3l6az98tmL4s/LNn+mRwuV4cg== http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#signature.MCwCFEFKQsXSuHrd http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8 http://purl.org/dc/terms/created 2018-03-30T11:10:41.920+02:00 http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8#signature.MCwCFEFKQsXSuHrd http://bio2rdf.org/drugbank:DB05484_nanopub.RAN4qGLbLF66cPv8g14BToiC8GnYz4FRpHbxET6XEpWt8 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://purl.org/dc/terms/identifier 7720f136-841b-4851-a6e4-ad20a409a475 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234